Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
05/04/1993 | US5208259 Diaryl ether hetrocycles |
05/04/1993 | US5208251 Compounds for antiinflammatory agents, antiallergens, antiarthritic, antiulcer agents |
05/04/1993 | US5208241 N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity |
05/04/1993 | US5208218 T cell growth factor glycoproteins |
05/04/1993 | CA1317230C Aqueous preparation of 9-methyl-3-(1h-tetrazol-5-yl)- 4h-pyrido ¬1,2-a|pyrimidin-4-one potassium salt |
04/29/1993 | WO1993008284A1 M. paratuberculosis promoter and use thereof in immunogenic sequence expression |
04/29/1993 | WO1993008280A1 Recombitope peptides |
04/29/1993 | WO1993008279A1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
04/29/1993 | WO1993008259A2 Inhibitors of dipeptidyl-aminopeptidase type iv |
04/29/1993 | WO1993008215A1 Secreted mac-2-binding glycoprotein |
04/29/1993 | WO1993008207A1 Novel cytokine |
04/29/1993 | WO1993007900A1 In vitro antibody perfusion of kidney grafts |
04/29/1993 | WO1993007899A1 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS |
04/29/1993 | WO1993007887A1 Combined cellular and immunosuppressive therapies |
04/29/1993 | WO1993007863A1 Methods and compositions for treating allergic reactions |
04/29/1993 | WO1993007856A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
04/29/1993 | WO1993001165A3 Aromatic compounds, compositions containing them and their use in therapy |
04/29/1993 | CA2121487A1 Combined cellular and immunosuppresive therapies |
04/29/1993 | CA2121235A1 In vitro antibody perfusion of kidney grafts |
04/29/1993 | CA2120911A1 Medicaments |
04/28/1993 | EP0539330A1 Process for the preparation of substituted indoles |
04/28/1993 | EP0539329A1 Acetenyl compounds useful as leukotrien antagonists |
04/28/1993 | EP0539319A2 Pharmaceutical cyclosporin composition |
04/28/1993 | EP0539117A1 Compounds useful as leukotriene antagonists |
04/28/1993 | EP0538783A1 N-phenyl-2-cyano-3-hydroxycrotonic acid amid derivatives and their use as medicaments having immunomodulating properties |
04/28/1993 | EP0538754A2 Use of antibody-containing preparations for immunosuppression |
04/28/1993 | EP0538477A1 Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient |
04/28/1993 | EP0538436A1 Novel quaternary ammonium salts, process for obtaining same and pharmaceutical compositions containing them |
04/28/1993 | EP0538399A1 Cyclic cell adhesion modulation compounds |
04/28/1993 | EP0538392A1 3-phenyl-5,6-dihydrobenz c]acridine-7-carboxylic acids and related compounds as immunosuppresive agents |
04/28/1993 | EP0538384A1 Oxamides |
04/28/1993 | EP0538330A1 Beta-alethine use in cell culture and therapy. |
04/28/1993 | CN1071423A Bicyclic carboxylic acid derivatives |
04/28/1993 | CN1071420A 4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl) phenyl)-5-methyl-3h-1,2,4-triazol-3-one derivatives |
04/28/1993 | CN1071334A Solid for mulation containing amide derivative and process for preparing same |
04/27/1993 | US5206345 Binding specifically to epitope of cell surface; monoclonal antibodies and antigen-binding fragments |
04/27/1993 | US5206343 Oligopetides with cyclic proline-analogous amino acids |
04/27/1993 | US5206255 Heterocyclic compound |
04/27/1993 | US5206229 Inhibit cell proliferation, antiinflammatory, treating imbalance of immune system |
04/27/1993 | US5206014 Activating antibody response |
04/27/1993 | US5206008 Using androstene(diol or triol) |
04/27/1993 | CA1316932C Methods and compositions for inhibiting lipoxygenase |
04/27/1993 | CA1316929C Method of inhibiting virus |
04/27/1993 | CA1316916C Hydroxide mediated fk-506 rearrangement product |
04/27/1993 | CA1316649C Moulding contact lenses |
04/26/1993 | CA2081303A1 Process for the preparation of substituted indoles |
04/26/1993 | CA2081262A1 Acetylene compounds |
04/25/1993 | CA2081133A1 Pharmaceutical compounds |
04/24/1993 | CA2081173A1 N-phenyl-2-cyano-3-hydroxycrotonamide derivatives and their use as pharmaceuticals having an immunomodulatory property |
04/21/1993 | EP0538000A1 Indole and indazole carbamates as leukotriene antagonists |
04/21/1993 | EP0537949A1 Antiproliferative derivatives of 4H-naphtho 1,2-b pyran |
04/21/1993 | EP0537354A1 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
04/21/1993 | EP0537353A1 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
04/21/1993 | EP0537293A1 Ligand for cd28 receptor on b cells and methods |
04/21/1993 | EP0537269A1 Novel immunosuppressive compounds. |
04/21/1993 | EP0537191A1 Treatment of organ transplantation rejection |
04/21/1993 | EP0479871B1 Novel vitamin d analogues |
04/21/1993 | EP0343248B1 Novel polypeptide and method for preparing the same |
04/21/1993 | CN1071164A 含氮杂环化合物 Nitrogen-containing heterocyclic compounds |
04/20/1993 | US5204446 Polypeptide having immunoreactivity with antibody specific to hepatitis b virus |
04/20/1993 | US5204374 Cycloalkano(b)dihydroindoles and -indolesulphonamides substituted by heterocycles |
04/20/1993 | US5204346 Pyrazolopyridine compounds |
04/20/1993 | US5204338 Oxalylamino acid derivatives and their use as medicaments for inhibiting proline hydroxylase |
04/20/1993 | US5204329 4-Quinoline carboxylic acid derivatives |
04/20/1993 | CA1316534C Tetrahydronaphthaline and indane derivatives |
04/20/1993 | CA1316459C Method of inhibiting virus |
04/20/1993 | CA1316458C Pharmaceutical composition for piperidinoalkanol derivatives |
04/18/1993 | CA2080405A1 Indole carbamates as leukotriene antagonists |
04/15/1993 | WO1993007288A1 Macrophage activating factor from animal vitamin d-binding protein |
04/15/1993 | WO1993007146A1 Benzo and pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity |
04/15/1993 | WO1993007124A1 Nitrogenous heterocyclic compound |
04/15/1993 | WO1993007111A1 Cyclopentane and cyclopentene derivatives with antiallergic antiinflammatory and tumor necrosis factor inhibiting activity |
04/15/1993 | WO1993006867A1 The regulation of systemic immune responses utilizing cytokines and antigens |
04/15/1993 | WO1993006866A2 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
04/15/1993 | WO1993006864A1 Preventing allograft rejection with antibodies to adhesion molecules |
04/15/1993 | WO1993006852A2 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
04/15/1993 | WO1993006832A1 Method of treating hiv infection |
04/15/1993 | WO1993006824A1 Preparations containing transition-metal compounds for anti-tumour therapy and/or stimulating the haematopoietic system |
04/15/1993 | WO1993006812A2 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
04/15/1993 | DE4134158A1 Verwendung von wasser- oder lipidloeslichen uebergangsmetallverbindungen pharmazeutische zubereitungen und verfahren zur herstellung pharmazeutischer zubereitungen fuer die antitumortherapie und/oder stimulierung des haematopoetischen systems Use of water or lipidloeslichen by transition metal compounds pharmaceutical preparations and process for manufacture of pharmaceutical preparations for the antitumor therapy and / or stimulation of the hematopoietic system |
04/15/1993 | DE4134156A1 9-substituierte bicyclo(3.3.0)octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung 9-substituted bicyclo (3.3.0) octane derivatives, process for their production and their pharmaceutical use |
04/15/1993 | DE4133694A1 Verwendung einer emulsion, zur herstellung eines arzneimittels zur iv-verabreichung zur behandlung von hauterkrankungen Use of an emulsion, for the manufacture of a medicament for intravenous administration for the treatment of skin diseases |
04/15/1993 | CA2120500A1 Preventing allograft rejection with antibodies to adhesion molecules |
04/15/1993 | CA2120351A1 Cyclopentane and cyclopentene derivatives with antiallergic antiinflammatory and tumor necrosis factor inhibiting activity |
04/15/1993 | CA2120140A1 Method of treating hiv infection |
04/15/1993 | CA2116336A1 Nitrogenous heterocyclic compound |
04/14/1993 | EP0537070A1 Compositions containing compound TMK688 and its analogs |
04/14/1993 | EP0536896A1 Imidazolidyl macrolides having immunosuppressive activity |
04/14/1993 | EP0536817A1 Azabicyclic compounds as tachykinin antagonists |
04/14/1993 | EP0536807A1 Monoclonal antibodies and their use |
04/14/1993 | EP0536564A2 Method to purify streptolysin O, intact streptolysin O obtainable by this method and its use |
04/14/1993 | EP0536401A1 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
04/14/1993 | EP0536400A1 Tetrazole derivative and medicine |
04/14/1993 | EP0536343A1 Targeted polymeric conjugates of cyclosporin and method for their preparation. |
04/14/1993 | EP0536322A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(a) |
04/14/1993 | EP0536299A1 Surface complexed lymphotoxin |
04/14/1993 | EP0536275A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
04/14/1993 | EP0536119A1 Immunoregulatory agents |
04/14/1993 | CN1070910A Thiazolylbenzofuran derivatives, processes for preparation thereof and pharmaceutical composition comprising same |
04/13/1993 | US5202422 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use |